Genmab: CEO Lisa N. Drakeman retires
Dr. Drakeman has served as Genmab’s President and CEO since inception and is also a member of the board of directors. Dr. Drakeman has over 18 years of experience working in the biotechnology industry, including establishing corporate partnerships with major pharmaceutical companies, managing clinical trials and developing government programs for financing biotechnology research.
Dr. Drakeman previously served as a member of the faculty and administration at Princeton University and as Senior Vice President, Head of Business Development for Medarex, Inc. Dr. Drakeman serves on the board of BioNJ. ■